Today: 21 May 2026
Aviva share price rises as UBS says insurer is “better protected” ahead of March results
28 January 2026
1 min read

Aviva share price rises as UBS says insurer is “better protected” ahead of March results

London, Jan 28, 2026, 09:39 GMT — Regular session

  • Aviva’s stock edged up roughly 0.9% during early London trading.
  • UBS singled out Aviva as its top pick among UK life insurers, favoring it over Legal & General.
  • Investors are eyeing March 5 for results, looking closely at buyback updates and details on Direct Line integration.

Aviva shares climbed roughly 0.9% to 631.6 pence on Wednesday, with investors gearing up for the insurer’s full-year results set for March 5.

The move is modest, but the timing is key. Aviva’s upcoming update should provide concrete figures on cash returns — dividends and buybacks — revealing if the Direct Line integration is translating into capital and earnings instead of just headlines.

UBS analyst Nasib Ahmed reiterated on Jan. 26 that the bank favors Aviva over Legal & General, highlighting its “well-protected balance sheet, high capital generation yield and diversification.” Proactiveinvestors UK

UBS has set a 750p target on Aviva, per an Interactive Investor report, and contends Aviva holds up better than Legal & General in a market stress test. “Our sensitivity analysis indicates that Aviva is much better protected under a market stress,” the bank noted. Interactive Investor

That “protection” mainly refers to solvency — the capital buffer insurers are required to maintain under Solvency II regulations. A bigger buffer gives management extra leeway to continue dividends or resume buybacks during market turbulence.

Aviva has been integrating Direct Line since last year, following approval from the UK competition watchdog. The insurer has told investors it expects quicker earnings growth and larger cost savings from the merger.

Earlier this month, Aviva announced that the Prudential Regulation Authority had approved its request to revoke Direct Line’s Solvency II partial internal model. The group said this move paves the way to transition Direct Line onto Aviva’s own model gradually. Aviva also confirmed it remains on track to deliver over £500 million in total capital synergies by around the end of 2026.

The broader London market showed strength this week, with the FTSE 100 finishing Tuesday up 0.6% thanks to gains in bank shares. Investors were also focused on an upcoming U.S. Federal Reserve decision.

Insurers face a snag, though. When credit spreads widen or equity markets tumble, solvency can deteriorate fast. The strain typically hits buyback programs and “extra” distributions first.

Aviva’s full-year results drop on March 5 at 0700 GMT, offering investors a crucial update. The group is set to clarify its capital return strategy for 2026 and provide a clearer picture of Direct Line’s performance within the figures.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Diageo share price rebounds, but JPMorgan still sees downside ahead of interims
Previous Story

Diageo share price rebounds, but JPMorgan still sees downside ahead of interims

Legal & General share price: LGEN ticks up as L&G names new real assets chiefs, Banner Life sale in focus
Next Story

Legal & General share price: LGEN ticks up as L&G names new real assets chiefs, Banner Life sale in focus

Go toTop